
|Videos|October 19, 2021
AMCP Nexus 2021: Jane F. Barlow, M.D., M.P.H., MBA, MIT Center for Biomedical Innovation, Addresses Gene, Cell Therapy and Needed Adjustments of High Costs for Payment Models
Author(s)Peter Wehrwein
Barlow spoke at AMCP Nexus about gene and cell therapy and about how payment models need to adjust to account for their high initial cost and their durable — in some cases lifetime — effects.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
Medicaid tech companies pledge $600 million to help states update systems
4
When it comes to quality measures, fewer is viewed as better, says Ben Shirley of PQA | Part 2
5























